Lucy 2.0 (Novel Psilocybin Analog)

About Lucy Scientific Discovery

Lucy Scientific Discovery is positioning itself at the intersection of neuroscience and psychedelic medicine, aiming to develop and commercialize new therapeutic entities. The company leverages its status as a licensed dealer of controlled substances to conduct research and provide CRO services. Its strategic direction involves building a pipeline of proprietary drug candidates while generating early revenue through its contract research capabilities. As a public company, it seeks to capitalize on the growing investment and regulatory interest in psychedelic-assisted therapies.

Therapeutic Areas